Pilihan
AWG Kibarkan Bendera Indonesia-Palestina di Gunung Raung
Airia Enables Enterprise-Grade Security for OpenClaw AI Agent Deployments
AI Management Leader Delivers Solution for Securing OpenClaw with Gateway Technology
ATLANTA, March 20, 2026 (GLOBE NEWSWIRE) -- Airia, the enterprise AI management platform, today announced enterprise security capabilities for OpenClaw (formerly known as Clawdbot and Moltbot), addressing critical safety concerns as organizations rapidly adopt the powerful AI agent technology.
A well-known healthcare organization just deployed OpenClaw through Airia's AI Gateway, enabling secure, monitored access to the viral AI assistant while maintaining HIPAA compliance and data protection standards. The deployment demonstrates how enterprises can harness OpenClaw's impressive capabilities while mitigating security risks that have raised concerns across the industry.
"OpenClaw represents a breakthrough in AI agent capabilities, but it carries significant security risks that make it unsuitable for enterprise use without proper guardrails," said Kevin Kiley, CEO of Airia. "Our AI Gateway makes OpenClaw trusted and safe for business environments by providing observability, data loss prevention, and agent constraints—allowing organizations to innovate confidently with cutting-edge AI."
Airia's solution addresses OpenClaw security challenges through multiple protection layers:
Data Loss Prevention (DLP): Real-time auditing of health information, personally identifiable information (PII), and sensitive data within OpenClaw requests and responses
Complete Observability: Full visibility into OpenClaw interactions, costs, and usage patterns across the organization
Agent Constraints: Intelligent guardrails that control OpenClaw behavior and limit potential security exposure
Routing Engine: Advanced protections against AI agent failures and unexpected behaviors
The platform enables IT teams to configure OpenClaw for employees while maintaining centralized control, monitoring, and security enforcement—critical capabilities for regulated industries and security-conscious enterprises.
"Organizations shouldn't have to choose between innovation and security," added Kiley. "Airia makes OpenClaw enterprise-ready today, while providing a clear path to our more configurable and transparent Omni platform as customers mature their AI strategies."
As OpenClaw adoption accelerates, Airia provides the governance infrastructure necessary to prevent shadow AI risks and ensure responsible AI agent usage at scale.
About Airia
Founded in 2024, Airia delivers the industry’s first unified enterprise AI security, orchestration, and governance platform, purpose-built to accelerate AI adoption. Airia guides the world’s most innovative enterprises through their AI transformation journey by addressing the critical gap between rapid innovation and governance requirements-empowering teams to build and deploy AI agents fast while maintaining enterprise-grade control. Learn more at airia.com.
Media Contact
Julia Harold
juliaharold@airia.com
Copyright 2026 GlobeNewswire, Inc.
.png)

Berita Lainnya
onsemi Powers Sineng Electric's Advanced Solar and Energy Storage Solutions
Teva Releases Q2 2026 Aide Memoire
Sompo announces Henry MacHale as Chief Underwriting Officer and Head of Strategy, International Markets
Movement Berinvestasi di Stableyard untuk Membangun Lapisan Pengalaman Pembayaran Stablecoin yang Menyeluruh
Orano Meningkatkan Kepemilikan Saham di Tambang Cigar Lake di Kanada
Alibaba Unveils Qwen3.6-Plus to Accelerate Agentic AI Deployment for Enterprises and Alibaba's AI Applications
Copenhagen Infrastructure Partners partially divests 500MW Devilla BESS project to Scottish National Investment Bank and Nuclear Liabilities Fund
Movement Berinvestasi di Stableyard untuk Membangun Lapisan Pengalaman Pembayaran Stablecoin yang Menyeluruh
Curia Memperluas Kapasitas Manufaktur Glasgow dan Meningkatkan Platform Pengembangan Lini Sel
Tuiga and Viola set sail for the United States Tuiga and Viola set sail for the United States
Teva's Data on AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care
Spectra Defense Technologies Unveils XSR Spire Ruggedized Mission Computer